Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bupivacaine hydrochloride + isopropyl alcohol + povidone-iodine + lidocaine
- Development stage
- Unknown
- Lead developer
- Advanced Rx of Tennessee
- Modality
- Small Molecules
- Administration
- Parenteral, Topical
01
Overview
**Bupivacaine hydrochloride + isopropyl alcohol + povidone-iodine + lidocaine** is a procedural local anesthesia combination kit marketed as **Point of Care LM 2.2**. The kit combines two amide-type small-molecule local anesthetics, bupivacaine hydrochloride and lidocaine hydrochloride, with topical antiseptic skin-preparation components, isopropyl alcohol and povidone-iodine. Its intended use is to facilitate local or regional anesthesia for surgical, diagnostic, and therapeutic procedures, with the anesthetic effect mediated primarily by reversible blockade of voltage-gated sodium channels in peripheral nerves, thereby preventing initiation and conduction of nerve impulses. The antiseptic components are used for injection-site preparation rather than providing the anesthetic pharmacology. Public context provided indicates distribution by AuroMedics Pharma and use in anesthesia.
- Brand names
- Point of Care LM 2.2
- Other names
- bupivacaine hydrochloride + isopropyl alcohol + povidone-iodine + lidocainebupivacaine hydrochloride + lidocaine hydrochloride + isopropyl alcohol + povidone-iodine
02
Targets
NaV (Voltage-gated sodium channels)Kir (Inward-rectifier potassium channels)
Beyond the preview
Go deeper on bupivacaine hydrochloride + isopropyl alcohol + povidone-iodine + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bupivacaine hydrochloride + isopropyl alcohol + povidone-iodine + lidocaine.